Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Nutriband Inc (NTRB)

Nutriband Inc (NTRB)
4.71 x 1 5.59 x 3
Post-market by (Cboe BZX)
5.23 +0.17 (+3.36%) 04/23/25 [NASDAQ]
4.71 x 1 5.59 x 3
Post-market 5.23 unch (unch) 15:59 ET
Quote Overview for Wed, Apr 23rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
5.07
Day High
5.31
Open 5.07
Previous Close 5.06 5.06
Volume 14,000 14,000
Avg Vol 12,895 12,895
Stochastic %K 44.71% 44.71%
Weighted Alpha -50.58 -50.58
5-Day Change +0.32 (+6.52%) +0.32 (+6.52%)
52-Week Range 3.30 - 11.78 3.30 - 11.78
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 56,196
  • Shares Outstanding, K 11,106
  • Annual Sales, $ 2,090 K
  • Annual Income, $ -5,490 K
  • EBIT $ -6 M
  • EBITDA $ -6 M
  • 60-Month Beta 1.19
  • Price/Sales 24.80
  • Price/Cash Flow N/A
  • Price/Book 5.06

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 01/31/25
See More
  • Average Estimate -0.12
  • Number of Estimates 1
  • High Estimate -0.12
  • Low Estimate -0.12
  • Prior Year -0.16
  • Growth Rate Est. (year over year) +25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.51 +15.96%
on 04/07/25
Period Open: 6.73
6.85 -23.65%
on 03/25/25
-1.50 (-22.29%)
since 03/21/25
3-Month
4.51 +15.96%
on 04/07/25
Period Open: 9.90
10.50 -50.19%
on 01/24/25
-4.67 (-47.17%)
since 01/23/25
52-Week
3.30 +58.48%
on 05/02/24
Period Open: 3.56
11.78 -55.60%
on 01/23/25
+1.67 (+46.91%)
since 04/23/24

Most Recent Stories

More News
Nutriband (NASDAQ: NTRB): Building a Moat Around Abuse-Deterrent Drug Delivery

Nutriband (NASDAQ: NTRB) continues to solidify its leadership in the development of abuse-deterrent transdermal pharmaceuticals. In February, the company received a trademark registration from the U.S....

NTRB : 5.23 (+3.36%)
BMWYY : 29.2000 (+4.58%)
Nutriband (NASDAQ: NTRB) CEO Named EY Entrepreneur of the Year 2025 Finalist

Nutriband (NASDAQ: NTRB) CEO Gareth Sheridan has been named a finalist in the Established category of the 2025 EY Entrepreneur of the Year Awards. Sheridan is one of 27 Irish entrepreneurs recognized for...

NTRB : 5.23 (+3.36%)
BMWYY : 29.2000 (+4.58%)
Nutriband (NASDAQ: NTRB) Is ‘One to Watch’

Nutriband (NASDAQ: NTRB) is engaged in the development of a portfolio of transdermal pharmaceutical products. The company’s AVERSA(TM) technology can be incorporated into any transdermal patch and includes...

NTRB : 5.23 (+3.36%)
BMWYY : 29.2000 (+4.58%)
Nutriband (NASDAQ: NTRB) Secures Patent in Macao for AVERSA Abuse-Deterrent Technology

Nutriband (NASDAQ: NTRB), a developer of prescription transdermal pharmaceutical products, has been granted a patent in Macao for its AVERSA abuse-deterrent transdermal technology. The patent, titled “Abuse...

NTRB : 5.23 (+3.36%)
Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology

NTRB : 5.23 (+3.36%)
NTRBW : 1.3350 (+4.30%)
Nutriband (NASDAQ: NTRB) Signs Partnership Deal With Charlotte FC to Boost Brand Visibility

Nutriband (NASDAQ: NTRB), a developer of transdermal pharmaceutical products, has entered into an Associate Partnership agreement with Charlotte FC to raise awareness of its flagship brands, including...

NTRB : 5.23 (+3.36%)
BMWYY : 29.2000 (+4.58%)
UPDATE – Nutriband Signs Associate Partnership with Charlotte FC

NTRB : 5.23 (+3.36%)
NTRBW : 1.3350 (+4.30%)
Nutriband (NASDAQ: NTRB) Signs Partnership Deal With Charlotte FC to Boost Brand Visibility

Nutriband (NASDAQ: NTRB), a developer of transdermal pharmaceutical products, has entered into an Associate Partnership agreement with Charlotte FC to raise awareness of its flagship brands, including...

NTRB : 5.23 (+3.36%)
BMWYY : 29.2000 (+4.58%)
Nutriband Signs Partnership Agreement with Charlotte FC

NTRB : 5.23 (+3.36%)
NTRBW : 1.3350 (+4.30%)
Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.

NTRB : 5.23 (+3.36%)
NTRBW : 1.3350 (+4.30%)

Business Summary

Nutriband Inc. is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. The company is engaged in developing to provide clinicians and patients with an abuse deterrent transdermal fentanyl product for use in managing chronic pain requiring opioid therapy. Nutriband...

See More

Key Turning Points

3rd Resistance Point 5.71
2nd Resistance Point 5.55
1st Resistance Point 5.39
Last Price 5.23
1st Support Level 5.07
2nd Support Level 4.91
3rd Support Level 4.75

See More

52-Week High 11.78
Fibonacci 61.8% 8.54
Fibonacci 50% 7.54
Fibonacci 38.2% 6.54
Last Price 5.23
52-Week Low 3.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective